Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arq. bras. med. vet. zootec ; 67(6): 1684-1692, nov.-dez. 2015. tab
Artigo em Português | LILACS | ID: lil-768165

RESUMO

O presente experimento, conduzido no Laboratório de Ovinocultura da Universidade Federal de Santa Maria, teve como objetivo avaliar o efeito do uso de diferentes dietas de alto grão sobre o consumo de nutrientes e o desempenho de cordeiros terminados em confinamento, bem como realizar uma análise econômica da alimentação utilizada para terminação dos animais. Foram utilizados 32 cordeiros machos, castrados, da raça Texel, nascidos de parto simples e desmamados com aproximadamente 50 dias de idade. Os tratamentos foram constituídos por diferentes tipos de grãos, não processados, sendo: grão de milho, grão de aveia branca, grão de aveia preta ou grão de arroz com casca. Os animais foram abatidos quando atingiram o peso vivo de abate pré-estabelecido de 32kg, que corresponde a 60% do peso adulto de suas mães. Cordeiros alimentados com dietas de alto grão de milho apresentam maiores consumos de matéria seca, matéria orgânica, proteína bruta, carboidratos totais e de nutrientes digestíveis totais, menor consumo de fibra em detergente neutro, melhor escore de condição corporal, ganho de peso e conversão alimentar, o que leva à redução do número de dias no confinamento necessários para atingir o peso de abate. Além disso, cordeiros terminados com o uso de dieta de alto grão à base de grão de milho proporcionam melhor resultado econômico quando comparados com cordeiros terminados com as demais dietas de alto grão utilizadas neste experimento. O uso de dietas de alto grão de milho, aveia branca, aveia preta ou arroz com casca para terminação de cordeiros em sistema de confinamento é uma alternativa viável do ponto de vista produtivo. Porém, o uso de grão de milho proporciona melhores resultados produtivos e econômicos.


This experiment was conducted at the Laboratory of Sheep, Federal University of Santa Maria, and aimed to evaluate the effect of using different high-grain diets on nutrient intake and performance of lambs in a feedlot, as well as conduct an economic analysis of feeding used for termination of the animals. A total of 32 Texel breed castrated male lambs, born from a simple birth and weaned at approximately 50 days of age were used. The treatments consisted of different types of grains, unprocessed, as follows: corn grain, white oat grain, black oat grain or grain of rice in the husk. The animals were slaughtered when they reached a pre-established body weight of 32kg for slaughter, which corresponds to 60% of the mature weight of their mothers. Lambs fed diets with high corn grain have higher intakes of dry matter, organic matter, crude protein, total digestible nutrients and total carbohydrate, lower consumption of neutral detergent fiber and better body condition score, weight gain and feed conversion, which leads to reduction in the number of days in confinement needed to reach slaughter weight. In addition, lambs using high-grain diet based grain corn provide better economic results when compared with lambs with other high-grain diets used in this experiment. The use of diets high in grain corn, white oat grain, black oat grain or grain of rice in the husk for finishing lambs in feedlot is a viable alternative from a productive point of view. However, the use of corn grain provides better performance and economic results.


Assuntos
Animais , Dieta/veterinária , Ovinos/metabolismo , Ração Animal/análise , Ração Animal , Aumento de Peso , Zea mays/metabolismo , Avena/metabolismo , Oryza/metabolismo
2.
Chemosphere ; 85(5): 717-23, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21722939

RESUMO

Bankside groundwater is widely used as drinking water resource and, therefore, contamination has to be avoided. In the European Union groundwater protection is explicit subject to Water Framework Directive. While groundwater pollution may originate from different sources, this study investigated on impacts via flood events. Groundwater was sampled with increasing distance to the river Rhine near Karlsruhe, Germany. Samples were HPLC-MS-MS analyzed for the river contaminant carbamazepine to indicate river water infiltration, giving permanent presence in 250 m distance to the river (14-47 µg L⁻¹). Following a flood event, concentrations of about 16-20 µg L⁻¹ could also be detected in a distance of 750 m to the river. Furthermore, estrogenic activity as determined with the Yeast Estrogen Screen assay was determined to increase up to a 17ß-ethinylestradiol equivalent concentration (E-EQ)=2.9 ng L⁻¹ near the river, while activity was initially measured following the flood with up to E-EQ=2.6 ng L⁻¹ in 750 m distance. Detections were delayed with increasing distance to the river indicating river water expansion into the aquifer. Flood suspended matter and floodplain soil were fractionated and analyzed for estrogenic activity in parallel giving up to 1.4 ng g⁻¹ and up to 0.7 ng g⁻¹, respectively. Target analysis focusing on known estrogenic active substances only explained < 1% of measured activities. Nevertheless, river water infiltration was shown deep into bankside groundwater, thus, impacting groundwater quality. Therefore, flood events have to be in the focus when aiming for groundwater and drinking water protection as well as for implementation of Water Framework Directive.


Assuntos
Estrogênios/análise , Inundações , Água Subterrânea/análise , Material Particulado/análise , Solo/análise , Poluentes Químicos da Água/análise , Analgésicos não Narcóticos/análise , Carbamazepina/análise , Monitoramento Ambiental/métodos , Alemanha , Rios/química
3.
Cancer Chemother Pharmacol ; 41(6): 505-12, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9554596

RESUMO

PURPOSE: The overall purpose of this study was to determine the potential usefulness of 1,19-di-(ethylamino)-5,10,15-triazononadecane (BE-4-4-4-4) in the treatment of prostate cancer using in vitro and in vivo models. More specifically the objectives were: (1) to determine the in vitro and in vivo sensitivity of human and rat prostate cancer cells to two polyamine analogues N1,N11-di(ethyl)norspermine (DENSPM) and BE-4-4-4-4; (2) to determine whether the mechanism of cell kill occurred through an apoptotic pathway; and (3) to determine the toxicity associated with therapeutic doses of BE-4-4-4-4 using an animal model. METHODS: In order to determine the ability of these drugs to cause in vitro cytotoxicity, colony-forming assays were performed utilizing the well-characterized Dunning rat prostate cancer cell lines AT3.1, AT6.1 and AT6.3, and the androgen-insensitive human prostate cancer cell lines DU145, DuPro-1 and TSU-Pr1. Apoptotic cell death was determined using DNA laddering and DAPI staining of nuclei. The antitumor activity of BE-4-4-4-4 was evaluated by treatment of DuPro- and PC-3 xenograft tumors in nude mice. RESULTS: BE-4-4-4-4 was shown to be approximately 4 to 86 times more cytotoxic in clonogenic assays than DENSPM in both rat and human prostate carcinoma cell lines. Cells treated with cytotoxic doses of DENSPM or BE-4-4-4-4 showed no signs of apoptosis using either DNA laddering or DAPI staining of nuclei. There was a significant inhibition of DuPro-1 tumors for animals treated with BE-4-4-4-4 compared with control animals. Equitoxic doses of BE-4-4-4-4 resulted in greater tumor inhibition than DENSPM, although the difference was not significant. After treatment with therapeutic doses of BE-4-4-4-4, histopathologic evaluation indicated minimal to mild necrosis and inflammation in the kidneys on days 15 and 22 following treatment. On day 35, there was no necrosis or regeneration present in the kidney, indicating that the toxicity was transient and that regeneration of epithelial cells was complete with apparent return to normalcy. CONCLUSIONS: These initial studies demonstrate that BE-4-4-4-4 is cytotoxic against rat and human prostate cancer cells in culture and effective against DuPro-1 xenografts in nude mice. Polyamine analogues, such as DENSPM or BE-4-4-4-4, should be considered for clinical use in the treatment of prostate adenocarcinomas.


Assuntos
Adenocarcinoma/tratamento farmacológico , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Neoplasias da Próstata/tratamento farmacológico , Espermina/análogos & derivados , Adenocarcinoma/patologia , Animais , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Feminino , Humanos , Rim/efeitos dos fármacos , Rim/patologia , Masculino , Camundongos , Camundongos Nus , Transplante de Neoplasias , Neoplasias da Próstata/patologia , Ratos , Espermina/farmacologia , Células Tumorais Cultivadas
4.
Cancer Res ; 54(17): 4698-702, 1994 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-8062267

RESUMO

The polyamine analogue 1,19-bis(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), 5 mg/kg i.p., was given twice daily on days 0-3 and 7-10 (cycle 1) to nude mice with human malignant gliomas (SF-767 and U-87 MG), lung adenocarcinoma (A549), and colon carcinomas (HCT116 and HT29). A second cycle of drug was given to mice with SF-767 and A549 tumors on days 42-45 and 49-52. The maximum animal weight loss varied between 4 and 12%, which was observed 10-15 days following the initiation of treatment, but no overt toxic reactions were noted. The SF-767 brain tumors were extremely responsive to BE-4-4-4-4 alone (3 of 8 complete regressions after 2 cycles); however, the growth of the U-87 MG brain tumor was only slightly inhibited by BE-4-4-4-4 treatment. There was significant inhibition of tumor growth after treatment with one cycle of BE-4-4-4-4 in animals carrying the A549, HCT116, and HT29 tumors. At day 73, the growth of the A549 tumor was inhibited by 78 and 89% following one or two cycles of BE-4-4-4-4, respectively. The mitotic index of A549 tumors was 18 times greater in control mice than in those treated with BE-4-4-4-4 for one or two cycles 99 days after initiation of treatment. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU) was given to mice carrying the U-87 MG or A549 tumors on day 4 (cycle 1) and day 46 (cycle 2) in the maximal tolerated dose of 50 mg/kg for BCNU alone and 40 mg/kg for BCNU plus BE-4-4-4-4. BCNU alone significantly inhibited the growth of U-87 MG tumors but not the growth of A549 tumors. Treatment with the combination of BCNU and BE-4-4-4-4 was significantly better than BCNU alone for A549 tumors and better than BE-4-4-4-4 alone for U87 tumors. However, in both animal groups treated with the combination, there was a significant weight loss, which was not observed for animals treated with either agent alone. These data suggest a role for BE-4-4-4-4 in the treatment of brain, lung, and colon tumors.


Assuntos
Espermina/análogos & derivados , Animais , Peso Corporal/efeitos dos fármacos , Neoplasias Encefálicas/tratamento farmacológico , Carmustina/uso terapêutico , Divisão Celular/efeitos dos fármacos , Neoplasias do Colo/tratamento farmacológico , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Glioblastoma/tratamento farmacológico , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Espermina/farmacologia , Transplante Heterólogo , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...